跳至主要内容
临床试验/NCT00698165
NCT00698165已完成不适用

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

AstraZeneca1 个研究点 分布在 1 个国家目标入组 2,400 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
2,400
试验地点
1
主要终点
Mini-Mental State Examination (MMSE), Disability Assessment for Dementia Scale (DAD), Neuropsychiatric Inventory Questionnaire (NPI-Q)

研究概览

简要总结

Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of possible or probable Alzheimer's disease, with or without vascular elements
  • The primary caregiver can be identified
  • The patient and his/her primary caregiver are both willing and able to participate in the study

排除标准

  • Patient or caregiver affected by alcohol or narcotics to the extent that it interferes with the completion of the study
  • Patient or caregiver does not understand English
  • Patient and/ or caregiver is the physician or physician's staff
  • Patient and/ or caregiver is a family member of the physician or physician's staff

结局指标

主要结局

Mini-Mental State Examination (MMSE), Disability Assessment for Dementia Scale (DAD), Neuropsychiatric Inventory Questionnaire (NPI-Q)

时间窗: Collected one time only

次要结局

  • Resource Utilization in Dementia (RUD)(collected one time only)
  • Short Form - 12 domains instrument (SF-12)(collected one time only)
  • World Health Organization Quality of Life instrument (WHO-QoL)(collected one time only)
  • Zarit Caregiver Burden Interview (ZBI)(collected one time only)
  • 15 domains Quality of Life Index instrument (15D)(collected one time only)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验